Cancer news and cancer widget

(American Association for cancer Research) Researchers have identified 11 genotypes that may increase esophageal cancer risk, according to research published in the November issue of Cancer Prevention Research, a journal of the American Association for Cancer Research.

(American cancer Society) A new review outlines potential pharmaceutical, dietary, surgical, and other approaches to reducing the risk of breast cancer among women in the United States, and examines the evidence for specific recommendations.

According to a report published in the November 5 issue of JAMA, women with a high risk of cardiovascular disease who took a daily supplement of folic acid and vitamins B6 and B12 did not seem to reduce their likelihood of developing cancer - including breast cancer.

Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that it has made a decision to pursue a pivotal (Phase II/III) randomized trial using the combination of REOLYSIN(R) with paclitaxel/carboplatin in refractory patients with head and neck cancers. The decision was made following a review of results by the Company's Board of Directors from the Company's ongoing U.K.

If obesity rates continue to increase then the number of cancer cases in the UK could double in the next 40 years, a leading cancer expert has warned ahead of a conference of scientists specialising in the links between cancer and obesity. Professor Martin Wiseman, Medical and Scientific Adviser for World Cancer Research Fund (WCRF), believes today's children could face big increases in rates of cancer as adults unless something is done to curb the obesity crisis.

Genentech, Inc. (NYSE:DNA) today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) as a therapy for people with previously treated glioblastoma.

Canopus BioPharma, Inc. (OTC:CBIA) today announced that it has successfully completed the second phase of its cancer vaccine development. The specialized laboratory study was analyzed at the Southern Research Institute in Birmingham, Alabama. The study used the blood of healthy human volunteers, vaccinated with Canopus Biopharma's cancer vaccine peptides, which then demonstrated anti-cancer properties against a panel of 12 human cancer cell lines in tissue culture.

Researchers have identified 11 genotypes that may increase esophageal cancer risk, according to research published in the November issue of Cancer Prevention Research , a journal of the American Association for Cancer Research. "We observed a significantly increased risk of esophageal cancer with increasing numbers of risk genotypes," said Yuanqing Ye, Ph.D.

In a paper published in Genome Research on Nov. 4, scientists at the Genome Institute of Singapore (GIS) report that what was previously believed to be "junk" DNA is one of the important ingredients distinguishing humans from other species. More than 50 percent of human DNA has been referred to as "junk" because it consists of copies of nearly identical sequences.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the publication of a new study in Nature medicine by scientists from the University of Bonn in collaboration with Alnylam.